Oxford Biomedica plc
OXB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£26,360 | -£10,705 | -£32,485 | -£109,534 |
| Dep. & Amort. | £13,176 | £11,292 | £11,482 | £13,875 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £431 | £984 |
| Change in WC | £6,825 | -£17,173 | -£13,930 | -£7,459 |
| Other Non-Cash | £8,713 | £4,735 | -£4,275 | £79,031 |
| Operating Cash Flow | £2,354 | -£11,851 | -£39,199 | -£23,103 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1,509 | -£2,683 | -£4,813 | -£4,978 |
| Net Acquisitions | £194 | -£636 | £9,004 | £3,970 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £636 | £2,031 |
| Investing Cash Flow | -£1,315 | -£3,319 | £4,827 | £1,023 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£287 | -£283 | -£2,697 | £0 |
| Stock Issued | £94 | £533 | £16,993 | £229 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£7,608 | -£5,076 | -£2,476 | -£6,039 |
| Financing Cash Flow | -£7,801 | -£4,826 | £11,820 | -£5,810 |
| Forex Effect | -£11 | -£763 | -£177 | £2,176 |
| Net Chg. in Cash | -£6,773 | -£20,759 | -£22,307 | -£25,714 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £60,650 | £81,409 | £103,716 | £129,430 |
| End Cash | £53,877 | £60,650 | £81,409 | £103,716 |
| Free Cash Flow | £845 | -£14,534 | -£44,012 | -£28,081 |